Nature's Sunshine Products, Inc. (NATR)
| Market Cap | 385.64M +66.9% |
| Revenue (ttm) | 489.79M +7.3% |
| Net Income | 19.89M +96.5% |
| EPS | 1.10 +108.1% |
| Shares Out | 17.58M |
| PE Ratio | 19.94 |
| Forward PE | 17.98 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 123,274 |
| Open | 21.70 |
| Previous Close | 21.60 |
| Day's Range | 21.35 - 22.14 |
| 52-Week Range | 12.97 - 28.14 |
| Beta | 0.95 |
| Analysts | Strong Buy |
| Price Target | 35.00 (+59.6%) |
| Earnings Date | May 7, 2026 |
About NATR
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate in... [Read more]
Financial Performance
In 2025, NATR's revenue was $480.14 million, an increase of 5.67% compared to the previous year's $454.36 million. Earnings were $19.52 million, an increase of 153.65%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for NATR stock is "Strong Buy." The 12-month stock price target is $35.0, which is an increase of 59.60% from the latest price.
News
Nature's Sunshine Products Q1 Earnings Call Highlights
Nature's Sunshine Products NASDAQ: NATR reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company co...
Nature’s Sunshine price target raised to $37 from $33 at Canaccord
Canaccord raised the firm’s price target on Nature’s Sunshine (NATR) to $37 from $33 and keeps a Buy rating on the shares. The firm said they reported better than expected…
Nature's Sunshine Products Earnings Call Transcript: Q1 2026
Q1 2026 delivered 9% sales and 33% EBITDA growth, led by digital expansion and strong regional performance. Guidance for 2026 is reaffirmed, with investments in technology and product innovation expected to drive sustainable growth.
Nature's Sunshine Products Earnings release: Q1 2026
Nature's Sunshine Products released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Nature's Sunshine Products Slides: Q1 2026
Nature's Sunshine Products has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Nature's Sunshine Products Quarterly report: Q1 2026
Nature's Sunshine Products has published its Q1 2026 quarterly earnings report on May 7, 2026.
Nature's Sunshine Reports Strong First Quarter 2026 Results
Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature...
Nature’s Sunshine appoints John Hnanicek as chief technology officer
Nature’s Sunshine (NATR) announced that John Hnanicek has been appointed chief technology officer, effective May 4. Hnanicek most recently served as chief digital innovation officer at Melaleuca, wher...
Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer
Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strat...
Nature's Sunshine Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET
LEHI, Utah, April 23, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality h...
Nature's Sunshine Products Proxy statement: Proxy filing
Nature's Sunshine Products filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
Nature's Sunshine Products Slides: Investor presentation
Nature's Sunshine Products has posted slides in relation to its latest quarterly earnings report, which was published on April 9, 2026.
Nature's Sunshine Products Proxy statement: Proxy filing
Nature's Sunshine Products filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.
Nature's Sunshine Products Proxy statement: Proxy filing
Nature's Sunshine Products filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.
Nature’s Sunshine price target raised to $33 from $23 at DA Davidson
DA Davidson raised the firm’s price target on Nature’s Sunshine (NATR) to $33 from $23 and keeps a Buy rating on the shares. The company’s beat and raise trend continues…
Nature’s Sunshine price target raised to $33 from $29 at Canaccord
Canaccord analyst Susan Anderson raised the firm’s price target on Nature’s Sunshine (NATR) to $33 from $29 and keeps a Buy rating on the shares. The firm noted they reported…
Nature's Sunshine Products Earnings Call Transcript: Q4 2025
Record 2025 sales and EBITDA growth were driven by digital expansion, new customer acquisition, and strong consultant partnerships. 2026 guidance calls for 4–7% sales growth and continued investment in digital and innovation, with a long-term goal to double sales to $1 billion.
Nature's Sunshine Products Annual report: Q4 2025
Nature's Sunshine Products has published its Q4 2025 annual report on March 10, 2026.
Nature's Sunshine Products Earnings release: Q4 2025
Nature's Sunshine Products released its Q4 2025 earnings on March 10, 2026, summarizing the period's financial results.
Nature's Sunshine Products Slides: Q4 2025
Nature's Sunshine Products has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 10, 2026.
Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results
LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality h...
Nature’s Sunshine price target raised to $29 from $22 at Canaccord
Canaccord analyst Susan Anderson raised the firm’s price target on Nature’s Sunshine (NATR) to $29 from $22 and keeps a Buy rating on the shares. The firm updated its model…
Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET
LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional suppl...
Euromonitor International Names Synergy Pro-Argi-9+ the World's #1 L-Arginine Supplement
LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature's Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world's #1 l-arginin...
Nature’s Sunshine appoints Erich Fritz as EVP, global supply chain
Nature’s Sunshine (NATR) Products announced that Erich Fritz has been named Executive Vice President, Global Supply Chain, effective December 8, 2025. Mr. Fritz will report directly to Ken Romanzi, CE...